Key Takeaways:
- Australia’s pharmaceutical and biotech industry has grown 43% since 2019, accelerating demand for modernised Quality Assurance (QA) and Quality Control (QC) functions, and digitally fluent talent.
- Traditionally siloed QA and QC team structures are being replaced by unified digital ecosystems, powered by AI, LIMS, and QMS platforms.
- Hybrid lab roles are emerging as a direct response to legacy system modernisation in pharma and biotech, combining QA, QC, and digital capabilities in one role for greater efficiency.
- Data integrity failures continue to be a prevalent source of FDA pharmaceutical warning letters, contributing to Computer System Validation (CSV) being one of the fastest-growing and hardest-to-fill specialisms in the industry.
- 82% of senior pharma, biotech, and CRO leaders anticipate cross-functional roles will increase, with adaptability and digital fluency now core hiring criteria for hiring managers, who are looking beyond traditional experience in favour of combined skillsets.
The pharmaceutical and biotechnology industries in Australia are at the point of a meaningful shift. The sector itself has grown by 43% since 2019, with a compound annual growth rate of 5.88% and 7.8% in the pharmaceutical and biotechnology industry, respectively.
A more significant transformation is occurring slowly in Australian pharma and biotech as the digital infrastructure supporting QA and QC shifts. While paper-heavy functions traditionally dominated QA & QC in pharma and biotech, with heavily siloed legacy systems, technology is evolving these processes.
Unified data under a common technology, particularly with AI integration, is expected to improve QA & QC, with a single source of data, a more proactive approach, and faster decision-making. At a time when more than half of the executives surveyed by Deloitte said their organisations could achieve more automated and predictive lab capabilities. Research also suggests the average chemical QC lab could reduce costs by 25-45% by reaching the digitally enabled lab horizon, the business case is clear.
Pharma restructuring and biotech restructuring are sharpening the workforce, too. Growing demand across regulatory, tech, QA and QC, and digital health functions is exposing shortfalls in digital and data-led talent and a greater demand for hybrid skillsets.
Why Are Traditional Quality Assurance and Quality Control Team Structures Becoming Outdated?
Traditionally, QA and QC have been siloed into separate lanes, rarely sharing systems, data, or personnel. Legacy modernisation is revolutionising the approach to QA/QC functions by replacing outdated, fragmented workflows that were previously paper-heavy with AI-powered digital ecosystems.
This shift is causing multiple changes in QA/QC, including:
- A shift from reactive to predictive, digital QA, treating the quality assurance function as a driver of value within pharma organisations and a competitive advantage, improving patient safety and health outcomes in line with regulatory expectations. Companies that apply smart quality principles to QA have a 30% improvement in time to market, a line-of-sight impact on profit, and improvements in employee engagement.
- Improved compliance and data integrity, with Laboratory Information Management Systems (LIMS) and Electronic Document Management Systems (EDMS) replacing manual entry and preventing compliance gaps, aggregating standardised data for predictive control, whilst Quality Management Systems (QMS) provide clear root-cause traceability for proactive actions.
- Unified digital ecosystems, often powered by AI. The pharma restructuring and biotech restructuring of QA/QC impacts organisational change as much as technology, creating a need for hybrid lab roles that have professionals working across both functions to interpret data outputs from automated instruments.
The New Roles Emerging with Shifting QA/QC Functions
With pharma and biotech restructuring already underway, a new category of roles within QA/QC functions is inevitable, too. Pharma 4.0 in particular is creating greater demand for professionals who can validate the digital systems overtaking legacy paper systems.
Data integrity failures appear in 60-80% of FDA pharmaceutical warning letters issued, highlighting how important Computer System Validation (CSV) experts are to align with the stringent validation processes of the Therapeutic Goods Administration, FDA, and EMA. Additionally, whenever a business implements new software, conducts an audit, or updates a system, the compliance element falls to CSV professionals.
Subsequently, CSV is becoming a high-paying, high-demand job due to conventional degrees not equipping professionals with the regulatory validation required. This creates a skills gap that means CSV professionals are fewer in number but highly sought after. In this regard, CSV offers faster growth compared to traditional QA/QC roles.
Data-enabled QC is also an emerging role, with “T-shaped professionals” in high demand for combining deep scientific expertise with digital fluency in areas like LIMS. With Australia’s 35% talent shortfall in digital and data-driven roles, these professionals have a clear competitive hiring advantage.
In a survey of 500+ pharma, biotech, and CRO leaders, 82% of senior leaders anticipate cross-functional roles will increase, with an emphasis on adaptability and agility.
How Are Leading Pharma and Biotech Companies Redesigning Their Teams?
The leading pharma and biotech companies are investing in talent that have skills in digital automation, which can cut documentation errors by 70% and accelerate batch review cycles by 50% in a single year. Opting for generative AI and a predictive approach can result in a 25-45% reduction in QC lab costs through smart quality control, showing a clear business case for hiring those with digital automation skillsets.
QA teams in pharma and biotech are moving from a reactive and problem-finding approach to a more proactive, strategically significant one. The knock-on impact of this is that many QA professionals have more time to focus on high-level responsibilities (e.g., innovation, leadership).
More organisations will be redesigning teams based on hybrid QA/QC roles that sit between quality, validation, manufacturing, and technology/IT, rather than traditional, siloed roles. These smart quality teams need more data, automation, and systems capabilities and the skills to drive this change.
What Does This Mean for Hiring Managers?
The challenge for hiring managers in pharma and biotech organisations is that traditional quality assurance and quality control experience needs to now be blended with digital fluency, data analytics capabilities, and the flexibility to work across connected systems rather than isolated ones.
Change is already occurring that are restructuring pharma and biotech, so the emphasis is on sustaining this change through workforce transformation by hiring to create dedicated QA/QC teams that can examine stakeholder needs, manage expectations, and keep transitions to digital environments smooth and seamless.
Pipelines are likely to centre around digital ecosystems, proactive risk mitigation, and AI for data-driven analytics. It’s all about strategic legacy modernisation and finding the talent to deliver it.
Why Do Employers Partner with Evolve to Support Workforce Transformation in Regulated Environments?
Here at Evolve Scientific, our consultants combine their science degrees and experience working in the industry they now recruit for and combine it with expertise on navigating the complexities of regulated environments undergoing a period of transformation.
Backed by a global framework, our team provides on-the-ground support from our offices in Australia to provide flexible pharmaceutical recruitment and biotech recruitment solutions, from temporary hires up to management permanent hires and executive search.
We proudly partner with Australia’s leading scientific employers to build teams that innovate and lead at the forefront of their respective fields — contact our team for further insights on workforce transformation and hiring your ideal candidates for regulated environments today.
QA/QC Functions & Hybrid Roles in Pharma and Biotech: Frequently Asked Questions
What are QA/QC functions, and why are they essential in the pharma and biotech industries?
Quality Assurance is proactive and focused on preventing errors through stringent processes (e.g., SOPs, validation, training, CAPA), whereas Quality Control is reactive and focused on testing new products to detect any potential defects at the product level (e.g., lab testing, in-process checks).
What are hybrid lab roles, and how do they impact quality assurance and quality control?
Hybrid lab roles combine quality assurance and quality control responsibilities into one role, rather than two separate and siloed ones, blending digital skills like managing eQMS and keeping data quality accurate, to cover more ground efficiently.
What competencies should hiring managers look for in candidates for new QA/QC roles?
Hiring managers looking to fill QA/QC roles should look for a blend of skills that combine GMP, regulatory knowledge, and hands-on experience with data systems such as eQMS and LIMS to fill the gaps in the current workforce.
How can recruitment agencies support pharma and biotech companies in workforce transformation?
Life sciences recruitment agencies specialising in pharmaceutical and biotechnology can combine their industry expertise with flexible hiring solutions to build cross-functional teams that drive where the pharma and biotech industries are going with a compliant, efficient process.
How can Evolve Scientific assist with recruitment for quality assurance and quality control positions?
Evolve Scientific’s consultants aren’t just generalist recruiters. They are degree-qualified scientists with hands-on industry experience, meaning that they understand not just the skillsets required for QA/QC roles but also the precise technical competencies currently in demand in the industry.
What are the benefits of partnering with a specialist pharmaceutical and biotech recruitment agency?
Specialist pharmaceutical and biotech recruitment agencies aren’t generalist in approach, they are degree-qualified scientists with real industry experience that helps them to navigate the complex regulatory and compliance environment of hiring for these roles.
This often means faster, higher-quality hires without running the risk of compliance consequences, which is essential for roles across pharma and biotech.
